Navigation Links
Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
Date:5/8/2009

Ravensburg, Germany, May 8, 2009 / b3c newswire / - West (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, and Vetter, a worldwide leading independent specialist in the contract manufacturing of prefilled application systems, have introduced a ready-to-use, WFI prefilled syringe for reconstituting lyophilized drug products.

“The Vetter/West WFI syringe combines the best of pharmaceutical components in a drug administration system that we believe customers will embrace,” said Mike Schaefers, Vice President, Marketing, Europe, West. “This system can be applied to our customers’ high-value pharmaceutical and biopharmaceutical drug products.”
“This system unites two of the world’s leaders in drug administration systems and pharmaceutical processing,” said Oskar Gold, Vice President, Key Account Management, Vetter. “We are pleased that we can offer customers a world-class prefilled syringe system.”

The syringe features a plunger with West’s FluroTec® barrier film and Vetter’s V-OVS® tamper-evident closure, which includes a West tip cap. The film, developed by West’s partner, Daikyo Seiko, Ltd., provides an effective barrier against organic and inorganic extractables, which helps maintain the purity of the diluent.

The V-OVS® closure system is designed to give a prefilled syringe system effective protection features. It consists of a tip cap, a Vetter Luer Lock and a tamper-evident seal. The components are pre-assembled as a single part, which is mounted on the syringe barrel with a Luer-cone and Luer-groove. The integrity of the syringe system is maintained if the seal has not been broken.  The syringes are available with fill volumes between 0.5mL and 3.0mL. The glass syringe barrels are treated with baked silicone for lubricity and are 100 percent visually inspected to provide highest quality levels.

Customers will have packaging options, including individual blister packaging.
Vetter fills and terminally sterilizes the syringe at its facility in Langenargen, Germany. The syringes are supplied with regulatory documentation to meet requirements of markets in Europe, Japan, North America and numerous other countries.

About West
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

About Vetter
Vetter is an independent international specialist in the production of aseptically pre-filled injection systems, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds about 140 patents and has longstanding experience in handling client products and processes approved by the FDA, EMEA and other authorities.

FluroTec® is a registered trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions. 
FluroTec technology is licensed from Daikyo Seiko, Ltd. 
Vetter and V-OVS® are registered trademarks of Vetter Pharma-Fertigung GmbH& Co.KG in Germany, the United States and other jurisdictions. 
MixJect® is a registered trademark of Medimop Medical Projects Inc.


For more information contact 
Vetter Pharma International GmbH
Oskar Gold
Eywiesenstrasse 5
88212 Ravensburg
Germany
phone: +49-(0)751-3700 - 0
fax: +49-(0)751-3700 - 40 00
e-mail: info@vetter-pharma.com
www.vetter-pharma.com
'/>"/>

b3c newswire

Related biology news :

1. Improved e-jet printing provides higher resolution and more versatility
2. Canada provides $1.4M for removal of hazardous trees from provincial recreation sites
3. Study involving more than 100 scientists provides new insights on green algae
4. Shell Provides Consumers Gasoline Industrys First Pay By Touch Technology at the Pump
5. Book on little-known species and conservation provides guidance to managers and others
6. HIV isolate from Kenya provides clues for vaccine design
7. Antarctic expedition provides new insights into the role of the Southern Ocean for global climate
8. Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer
9. Scripps expedition provides new baseline for coral reef conservation
10. Researcher provides tool to enable determination of age of anchovies with greater precision
11. Research with squirrels provides clues on hormones role in human learning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:2/1/2016)... wallet ( www.wocketwallet.com ) announces the launch of a new video featuring ... Las Vegas , where Joey appeared at the Wocket booth ... , where Joey appeared at the Wocket booth to meet and ... at the Consumer Electronics Show (CES2016) in Las Vegas ... fans. --> --> The video ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
(Date:2/9/2016)... King of Prussia, PA (PRWEB) , ... February 09, 2016 , ... ... Director, Business Development, Europe. Based in Paris, he will focus on acquiring new ... needs are being met. , “Fred brings to our European clients ...
(Date:2/9/2016)... 9, 2016  DNAtrix, a clinical stage, ... announced that its lead product, DNX-2401, has ... an orphan medicinal product for the treatment ... glioma, strikes approximately 25,000 people a year ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
Breaking Biology Technology: